Search

everythinglearnresearchcommunity

for

Search:↓

International medical graduates scored higher than U.S. graduates on a medical exam.

In 1995, international medical graduates did better than U.S. graduates on a medical exam.

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Changes in gut and skin bacteria are linked to different hair loss conditions, and treatments like fecal transplants and probiotics might help, but more research is needed.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Trichovitals® supplement improves hair thickness, reduces hair loss, and promotes hair growth in young adults.

Minoxidil increases blood flow in balding scalps, possibly reversing hair loss.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Skin diseases are very common in poor areas, and there's a need for affordable ways to manage and improve skin health.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.